Posts

Blog Post

Antisense Therapeutics Announces Positive Results from Phase 2 Study of ATL1102 in DMD

By Jeanene Swanson | January 24, 2020
Featured Article

A Good Beginning: Newborn Screening

By Donna Albrecht | January 17, 2020
Featured Article

Living Not Suffering

By Christopher Carroll | January 16, 2020
Featured Article

Reasons Why You Should Get Genetic Testing

By Donna Albrecht | January 16, 2020
Featured Article

2019 Lasting Impression Photo Contest Winners

By MDA Staff | January 16, 2020
Featured Article

Advancing Health, One Research Study at a Time

By Cheryl Alkon | January 15, 2020
Blog Post

MDA Awards More Than $1 Million in Venture Philanthropy Funding to AavantiBio to Develop Gene-Targeting Therapy for Friedreich’s Ataxia

By Jeanene Swanson | January 13, 2020
Blog Post

FDA Approves ITF Pharma’s Tiglutik via PEG Tube for the Treatment of ALS

By Jeanene Swanson | December 20, 2019
MDA logo
Blog Post

Mallinckrodt Pharmaceuticals Releases Statement to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD

By MDA Staff | December 20, 2019
Blog Post

Amylyx Pharmaceuticals Announces Positive Results from Phase 2 Study of AMX0035 for Treatment of ALS

By Jeanene Swanson | December 19, 2019